Search Results for 'real-world evidence'
-
Clinical Trials | Drug Development
Three Ways Clinical Trials Will be Enhanced in 2020
Insights on the major changes shaping the clinical landscapeRichard Young, Henry Levy, Jim Reily, Veeva Systems 02.13.20
-
Breaking News | Drug Development | Industry News | Information Technology
Insilico, Pfizer Explore AI for Potential Therapeutic Targets
To use Insilico's machine learning technology and Pandomics Discovery Platform to identify real-world evidence for potential targets in a variety of diseases01.14.20
-
Information Technology
Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
The proven promise and huge potential of using AI and ML to accelerate drug discovery.Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 11.20.19
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
Contract Pharma’s 20th Anniversary Series: CRO Perspective
Randy Marchbanks of PPD discusses how CRO operations have evolved to accommodate changing industry needsOnline Exclusives Kristin Brooks, Contract Pharma 10.28.19
-
Drug Development | Information Technology
Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
The proven promise and huge potential of using AI and ML to accelerate drug discovery.Lucas Glass, Gary Shorter, and Rajneesh Patil, IQVIA 10.21.19
-
-
Clinical Trials | Drug Development
Contract Pharma’s 20th Anniversary Retrospective: Drug Development
A look back at the role of CROs in drug development and what we can expect for the futureOnline Exclusives Kristin Brooks, Contract Pharma 10.16.19
-
Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
FDA Extends CRADA with CluePoints
Aims to further explore a data-driven approach to quality oversight in clinical trials09.11.19
-
Clinical Trials | Information Technology | R&D
Leveraging Machine Learning and AI in Clinical Research
New streams of real-world data from electronic health records and other data sources, with advances in ML, will be crucial for creating next-gen clinical trialsJennifer Bradford, Ph.D., Head of Data Science at PHASTAR 08.19.19
-
Industry News | R&D
Syapse, FDA Announce RCA Using Real-World Evidence
Focus on advancing real-world oncology endpoints and providing insight into evidence-based clinical decision-making08.15.19
-
Collaborations & Alliances | Drug Development
Syapse, Pfizer in Oncology Precision Medicine Pact
To focus on outcomes research using Real-World Evidence07.24.19
-
-
Breaking News | CRO News | Industry News | Information Technology
Evidera to Acquire Medimix
Enhances ability to leverage data to provide real-world evidence and insights for clients05.31.19
-
Collaborations & Alliances | Drug Development
Amgen, Syapse Enter Precision Medicine Pact
To develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology05.03.19
-
Real World Evidence Developments Across the Globe
This article investigates how Real World Data and Real World Evidence are evolving across the U.S., Europe and Asia.Madhur Garg, Real World Evidence and Market Access, Sciformix, a Covance Company 04.05.19
-
Biologics, Proteins, Vaccines | Drug Development
Outsourcing & Emerging Biopharma
Richard Staub of IQVIA discusses the company’s new approach to providing clinical and commercial services for small biopharmaOnline Exclusives Kristin Brooks, Contract Pharma 02.27.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
PPD & HLT Enter Development Agreement
To create data science-driven clinical research solutions in China with the goal of enhancing global drug development02.20.19
-
Bio News | Industry News | Promotions & Moves | Regulatory Affairs
Former FDA Senior Executives Join PAREXEL
The industry veterans will work on the company's Regulatory Consulting group02.15.19
-
Breaking News | Clinical Trials | Collaborations & Alliances | CRO News | Information Technology
SHYFT Analytics, PAREXEL Enter Strategic RWE Pact
Will leverage SHYFT’s technology for Real-World Evidence generation and outcomes research11.12.18
-
Analytical Services | Bio News | Bioanalytical Services | Collaborations & Alliances | Industry News | Information Technology | R&D
Allergan Joins TriNetX Network
For real-time access to patient populations to determine protocol feasibility, cohort analysis and site identification10.10.18
-
Breaking News | Clinical Trials | CRO News | Drug Development | Information Technology
PAREXEL, Datavant in RWE Alliance
Aims to link healthcare data from a variety of real-world and clinical study data sources to improve drug development09.17.18
-
-
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Syneos, Elligo Enter Strategic Collaboration
To build a central infrastructure & research system around physicians & patients who aren't accessible in traditional sites06.21.18
-
CRO News | Drug Development | Laboratory Testing
LabCorp Acquires Sciformix Corp.
Expands pharmacovigilance capabilities for post-approval safety solutions06.11.18
-
Clinical Trials | Drug Development
CRO Perspectives: PAREXEL
Sy Pretorius addresses trends, what is and isn’t working well in partnership models, and where the industry can improveOnline Exclusives Kristin Brooks , Contract Pharma 06.01.18
-
Clinical Trials | CRO News | Drug Development | Information Technology
PPD, Evidera Join NEWDIGS Initiative at MIT
Collaboration aims to develop solutions for industry wide obstacles to biomedical innovation05.22.18
-
Clinical Trials | Drug Development
CRO Trends: IQVIA Perspective
IQVIA’s Richard Staub discusses R&D trends, opportunities, challenges and collaborationsOnline Exclusives Kristin Brooks, Managing Editor 05.14.18
-
Drug Development | Information Technology | R&D
CRO Industry Update: Big Data Drives Drug Development Efforts
With growth in virtual trials and RWE, the clinical development landscape may never look the sameKristin Brooks, Managing Editor 05.11.18
-
Clinical Trials | Information Technology
Transforming Clinical Ops with Technology Standards
Open technology standards aim to simplify trial execution and improve efficiency and productivity of clinical trialsOnline Exclusives Kristin Brooks, Contract Pharma 05.02.18
-
-
Collaborations & Alliances | CRO News | Industry News
-
Analytical Services | Bio News | Bioanalytical Services | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development
Roche Buys Flatiron for $1.9B
This total acquisition comes after their previous 12.6% stake in the company02.16.18
-
Industry News | Information Technology
Syapse, Roche Enter Precision Medicine Pact
Multi-year strategic collaboration aims to help make precision medicine available to more cancer patients01.09.18
-
Clinical Trials | Drug Development | Information Technology
Closing the Gap in Real-World Evidence
PAREXEL's Joshua Schultz discusses research challenges and the need for standards to overcome RWE limitationsOnline Exclusives Kristin Brooks, Contract Pharma 12.04.17
-
Breaking News | Clinical Trials | Industry News
Volume and Diversity of Clinical Trial Data Sources Expected to Soar
The Tufts survey report also says life sciences companies face the task of effectively managing the expanding sourcesOnline Exclusives Betsy Louda, Associate Editor 11.21.17
-
-
Clinical Trials | CRO News | Information Technology
PAREXEL, Microsoft Form Cloud Technology Alliance
Partnership will initially focus on moving PAREXEL Informatics technology and services onto Microsoft Azure10.24.17
-
Clinical Trials | CRO News
PAREXEL Launches Real-World Data Service Offering
Aims to help drive value demonstration of new treatments09.06.17
-
Clinical Trials | CRO News
-
Analytical Services | Bioanalytical Services | R&D
CROs & Next-Gen Drug Development
R&D trends drive outsourcing in today’s marketKristin Brooks, Contract Pharma 05.09.17
-
Clinical Trials | CRO News | Drug Development | Information Technology
-
Drug Development | Regulatory Affairs
How to Maximize Potential and Sidestep Pitfalls of MAPs
MAPs offers an ethical, compliant way to distribute investigational products to patients in need, but doing so is complicatedPhilippe Devos, World Wide Head, Managed Access Programs, Peggy Schrammel, Vice President, Scientific Affairs, and Kaushik Patel, Vice President, Market Access, PAREXEL International 04.01.17
-
Breaking News | CRO News | Industry News | Promotions & Moves | R&D
INC Research Makes Executive Appointments
Strengthens real world and late phase and global consulting capabilities03.31.17
-
Clinical Trials | CRO News | Drug Development | Information Technology
IMS Health, Quintiles to Merge
To become information and technology-enabled healthcare service provider05.03.16
-
CRO News | Drug Development | Risk Management
Quintiles Launches Asset Development Planning
IADP aims to facilitate strategic planning process, data analytics and modeling12.14.15
-
Clinical Trials | Drug Development | Validation
-
Clinical Trials | CRO News | Drug Development
PAREXEL Expands Evidence-based Services
Supports market access and lifecycle management for biopharma products11.09.15
-
Clinical Trials | Collaborations & Alliances | CRO News | Drug Development | Information Technology
Quintiles, IMS Health in Global RWE Alliance
Aims to advance the use of next-gen RWE in late-stage clinical research10.22.15
